(US9L) SP500 3x Daily Leveraged EUR - Overview
Etf: Equity, ETF, Leveraged, SP500
| Risk 5d forecast | |
|---|---|
| Volatility | 42.7% |
| Relative Tail Risk | -2.80% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.29 |
| Alpha | -4.36 |
| Character TTM | |
|---|---|
| Beta | 0.671 |
| Beta Downside | 1.118 |
| Drawdowns 3y | |
|---|---|
| Max DD | 51.84% |
| CAGR/Max DD | 0.83 |
Description: US9L SP500 3x Daily Leveraged EUR January 17, 2026
The WisdomTree S&P 500 3x Daily Leveraged EUR (XETRA: US9L) is a Germany-domiciled exchange-traded fund that seeks to deliver three times the daily performance of the S&P 500 Index, denominated in euros. As a leveraged equity product, its returns are reset each trading day, meaning compounding effects can cause performance to diverge significantly from a simple 3× multiple over longer horizons.
Key metrics (as of the most recent data) include a net asset value (NAV) of roughly €1.2 billion, an expense ratio of 0.75 % per annum, and an average daily trading volume of about 1.5 million shares on XETRA. The fund’s beta relative to the S&P 500 is approximately 3.02, confirming its targeted leverage factor.
Performance drivers are tightly linked to U.S. macro-economic conditions: a strong U.S. GDP growth rate, low unemployment, and accommodative Federal Reserve policy tend to boost the underlying index, amplifying US9L’s gains. Conversely, rising inflation expectations or abrupt monetary tightening can trigger rapid drawdowns, especially given the fund’s daily reset mechanism.
Sector exposure mirrors the S&P 500 composition, with technology (≈27 % of assets) and health care (≈13 %) as the largest weightings; these sectors are currently sensitive to earnings cycles and regulatory developments, which should be factored into any short-term tactical trade.
For a deeper, data-driven assessment of US9L’s risk-adjusted returns and scenario analysis, you may find the interactive dashboards on ValueRay useful.
What is the price of US9L shares?
Over the past week, the price has changed by -1.43%, over one month by -3.00%, over three months by +2.29% and over the past year by +6.07%.
Is US9L a buy, sell or hold?
What are the forecasts/targets for the US9L price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 155.2 | 24.7% |
US9L Fundamental Data Overview February 03, 2026
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 147.5m EUR (147.5m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 147.5m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 147.5m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 8.39% (E(147.5m)/V(147.5m) * Re(8.39%) + (debt-free company))
Discount Rate = 8.39% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)